2018
DOI: 10.1177/1933719117715126
|View full text |Cite
|
Sign up to set email alerts
|

Pain Mechanisms in Peritoneal Diseases Might Be Partially Regulated by Estrogen

Abstract: To identify factors influencing the differential pain pathogenesis in peritoneal endometriosis (pEM) and peritoneal carcinomatosis in ovarian cancer (pOC), we undertook an experimental study. Tissue samples of 18 patients with pEM, 15 patients with pOC, and 15 unaffected peritoneums as controls were collected during laparoscopy or laparotomy. Immunohistochemical stainings were conducted to identify nerve fibers and neurotrophins in the tissue samples. Additionally, 23 pEM fluids, 25 pOC ascites fluids, and 20 … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 62 publications
(80 reference statements)
0
1
0
Order By: Relevance
“…However, OCCC patients exhibit a highly heterogeneous prognosis [21]. Endometriosis is reported to be an independent risk factor for OCCC and ovarian endometriotic epithelial cells are considered as the cellular source of OCCC [22,23]. Even so, the mechanism of tumorigenesis has not been fully elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…However, OCCC patients exhibit a highly heterogeneous prognosis [21]. Endometriosis is reported to be an independent risk factor for OCCC and ovarian endometriotic epithelial cells are considered as the cellular source of OCCC [22,23]. Even so, the mechanism of tumorigenesis has not been fully elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…The pathological manifestation of EMs is characterized by extra-uterine growth of endometrial tissues. Apoptosis and proliferation imbalance [ 6 8 ], endocrine tolerance [ 9 , 10 ], oxidative stress [ 11 , 12 ], inflammation and immunity [ 13 ] and their interaction contribute to the high invasive ability of EMs cells. Although several medication lines including surgery, non-steroidal anti-inflammatory drugs, and hormones have been studied aiming at its definitive treatment, these therapies are difficult to avoid a range of side effects and high recurrence rates [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%